YU41875A - Process for preparing dry sodium 7-(d-2-formyloxy-2-phenylacetamido)-3-(1-methyl-1h-tetrazole-5-ylthiomethyl)-3-cephem-4-carboxylate - Google Patents

Process for preparing dry sodium 7-(d-2-formyloxy-2-phenylacetamido)-3-(1-methyl-1h-tetrazole-5-ylthiomethyl)-3-cephem-4-carboxylate

Info

Publication number
YU41875A
YU41875A YU00418/75A YU41875A YU41875A YU 41875 A YU41875 A YU 41875A YU 00418/75 A YU00418/75 A YU 00418/75A YU 41875 A YU41875 A YU 41875A YU 41875 A YU41875 A YU 41875A
Authority
YU
Yugoslavia
Prior art keywords
ylthiomethyl
phenylacetamido
cephem
formyloxy
tetrazole
Prior art date
Application number
YU00418/75A
Other languages
English (en)
Inventor
J M Indelicato
J M Greene
Original Assignee
Lilly Co Eli
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=23765656&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=YU41875(A) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Lilly Co Eli filed Critical Lilly Co Eli
Publication of YU41875A publication Critical patent/YU41875A/xx

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/16—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing nitrogen, e.g. nitro-, nitroso-, azo-compounds, nitriles, cyanates
    • A61K47/18—Amines; Amides; Ureas; Quaternary ammonium compounds; Amino acids; Oligopeptides having up to five amino acids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/54—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with at least one nitrogen and one sulfur as the ring hetero atoms, e.g. sulthiame
    • A61K31/542—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with at least one nitrogen and one sulfur as the ring hetero atoms, e.g. sulthiame ortho- or peri-condensed with heterocyclic ring systems
    • A61K31/545—Compounds containing 5-thia-1-azabicyclo [4.2.0] octane ring systems, i.e. compounds containing a ring system of the formula:, e.g. cephalosporins, cefaclor, or cephalexine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/02—Inorganic compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0019—Injectable compositions; Intramuscular, intravenous, arterial, subcutaneous administration; Compositions to be administered through the skin in an invasive manner

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Epidemiology (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • General Chemical & Material Sciences (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Engineering & Computer Science (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Dermatology (AREA)
  • Inorganic Chemistry (AREA)
  • Cephalosporin Compounds (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
YU00418/75A 1974-02-22 1975-02-21 Process for preparing dry sodium 7-(d-2-formyloxy-2-phenylacetamido)-3-(1-methyl-1h-tetrazole-5-ylthiomethyl)-3-cephem-4-carboxylate YU41875A (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US444622A US3928592A (en) 1974-02-22 1974-02-22 Antibiotic pharmaceutical compositions

Publications (1)

Publication Number Publication Date
YU41875A true YU41875A (en) 1982-05-31

Family

ID=23765656

Family Applications (1)

Application Number Title Priority Date Filing Date
YU00418/75A YU41875A (en) 1974-02-22 1975-02-21 Process for preparing dry sodium 7-(d-2-formyloxy-2-phenylacetamido)-3-(1-methyl-1h-tetrazole-5-ylthiomethyl)-3-cephem-4-carboxylate

Country Status (24)

Country Link
US (1) US3928592A (OSRAM)
JP (1) JPS6119605B2 (OSRAM)
AR (1) AR203895A1 (OSRAM)
AT (1) AT356264B (OSRAM)
BE (1) BE825653A (OSRAM)
CA (1) CA1043261A (OSRAM)
CH (1) CH620929A5 (OSRAM)
CS (1) CS189689B2 (OSRAM)
DD (1) DD117807A5 (OSRAM)
DE (1) DE2506622C2 (OSRAM)
DK (1) DK153919C (OSRAM)
ES (1) ES434976A1 (OSRAM)
FR (1) FR2261772B1 (OSRAM)
GB (1) GB1493676A (OSRAM)
HU (1) HU174129B (OSRAM)
IE (1) IE40671B1 (OSRAM)
IL (1) IL46650A (OSRAM)
NL (1) NL179976C (OSRAM)
PH (1) PH12058A (OSRAM)
PL (1) PL109311B1 (OSRAM)
SE (1) SE406153B (OSRAM)
SU (1) SU659094A3 (OSRAM)
YU (1) YU41875A (OSRAM)
ZA (1) ZA75975B (OSRAM)

Families Citing this family (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4054738A (en) * 1975-12-22 1977-10-18 Eli Lilly And Company Sodium cefamandole crystalline forms
JPS5283956A (en) * 1976-01-01 1977-07-13 Lilly Co Eli Antibiotic method and medical composition
JPS5329936A (en) * 1976-08-31 1978-03-20 Takeda Chem Ind Ltd Antibiotic composition
JPS5711909A (en) * 1980-06-23 1982-01-21 Shionogi & Co Ltd Stable freeze-dried preparation of beta-lactam
CA2011365A1 (en) * 1989-03-06 1990-09-06 Eugene L. Inman Diluent formulation for daptomycin
JP4873207B2 (ja) * 2001-02-26 2012-02-08 東レ・ファインケミカル株式会社 光学活性カルボン酸クロリドの精製方法
CN100554271C (zh) * 2007-07-27 2009-10-28 苏州中联化学制药有限公司 抗菌素头孢孟多酯钠的合成方法
CN101880290B (zh) * 2010-06-28 2012-03-07 海南新中正制药有限公司 头孢孟多酯钠的制备方法
WO2013057197A1 (en) * 2011-10-20 2013-04-25 Dsm Sinochem Pharmaceuticals Netherlands B.V. Process for the formylation of cefamandole
WO2013057196A1 (en) * 2011-10-20 2013-04-25 Dsm Sinochem Pharmaceuticals Netherlands B.V. Process for the preparation of cefamandole nafate
US9834567B1 (en) * 2014-12-16 2017-12-05 Tianjin University Crystalline form of cefamandole nafate compound, preparation and preparing method thereof

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE1767891C3 (de) * 1968-06-28 1980-10-30 Pfizer Verfahren zur Herstellung von wäßrigen arzneilichen Lösungen für die parenterale, perorale und lokale Anwendung mit einem Gehalt an einem Tetracyclinderivat
US3641021A (en) * 1969-04-18 1972-02-08 Lilly Co Eli 3 7-(ring-substituted) cephalosporin compounds

Also Published As

Publication number Publication date
DK65575A (OSRAM) 1975-10-20
DE2506622C2 (de) 1987-02-26
SE7501985L (OSRAM) 1975-08-25
JPS6119605B2 (OSRAM) 1986-05-17
PH12058A (en) 1978-10-18
AU7833975A (en) 1976-08-19
ATA128475A (de) 1979-09-15
DD117807A5 (OSRAM) 1976-02-05
FR2261772A1 (OSRAM) 1975-09-19
PL109311B1 (en) 1980-05-31
CH620929A5 (OSRAM) 1980-12-31
JPS50126817A (OSRAM) 1975-10-06
AR203895A1 (es) 1975-10-31
SE406153B (sv) 1979-01-29
IL46650A (en) 1977-10-31
HU174129B (hu) 1979-11-28
ZA75975B (en) 1976-09-29
SU659094A3 (ru) 1979-04-25
BE825653A (fr) 1975-08-18
CS189689B2 (en) 1979-04-30
IE40671L (en) 1975-08-22
GB1493676A (en) 1977-11-30
DK153919B (da) 1988-09-26
AT356264B (de) 1980-04-25
FR2261772B1 (OSRAM) 1980-01-04
IE40671B1 (en) 1979-07-18
IL46650A0 (en) 1975-05-22
ES434976A1 (es) 1976-12-16
NL179976B (nl) 1986-07-16
CA1043261A (en) 1978-11-28
NL7502045A (nl) 1975-08-26
DK153919C (da) 1989-02-06
DE2506622A1 (de) 1975-08-28
NL179976C (nl) 1986-12-16
US3928592A (en) 1975-12-23

Similar Documents

Publication Publication Date Title
JPS532494A (en) Process for preparing antibiotics
YU40413B (en) Process for obtaining cephem compounds
HU172431B (hu) Sposob poluchenija proizvodnykh fenola
YU41875A (en) Process for preparing dry sodium 7-(d-2-formyloxy-2-phenylacetamido)-3-(1-methyl-1h-tetrazole-5-ylthiomethyl)-3-cephem-4-carboxylate
YU36970B (en) Process for obtaining 7-(amino)-acylamido-3-halocephalosporins
HU172493B (hu) Sposob poluchenija proizvodnykh tienobenzodiazepina
YU323775A (en) Process for obtaining new cephalosporin compounds
YU37348B (en) Process for preparing cephalosporanic compounds
YU39004B (en) Process for preparing new xanthine derivatives
HU174949B (hu) Sposob poluchenija soedinenij 3-aminoalkiltio-indola
CH611289A5 (en) Process for preparing 7-substituted 8-aminomethylisoflavones
ZA755177B (en) Process for the preparation of cephalosporins
HU171325B (hu) Sposob poluchenija 2-amino-2-imidazolina
YU240474A (en) Process for obtaining novel cephem derivatives
HU172146B (hu) Sposob poluchenija proizvodnykh cinnolina
ZA753244B (en) Process for preparing cephalosporins
HU171206B (hu) Sposob poluchenija novykh proizvodnykh fenil-piridil-allilamina
HU174539B (hu) Sposob poluchenija novykh bu-2183 antibiotikov
HU175226B (hu) Sposob poluchenija soedinenij tipa sul'finil-azetidinona
HU171670B (hu) Sposob poluchenija nitril'nykh soedinenij oktenov
ZA755031B (en) Process for making cephalosporins
HU173555B (hu) Sposob poluchenija 11beta-gidroksi-18-metil-ehstrannykh soedinenij
JPS52113996A (en) Process for preparing 77alkoxyy 33chloromethyl cephem
YU98775A (en) Process for obtaining cephalosporin compounds
JPS52128392A (en) Process for preparing 33hydroxymethyl cephem